Tempest Therapeutics Stock Alpha and Beta Analysis
| TPST Stock | USD 1.10 0.01 0.92% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Tempest Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Tempest Therapeutics over a specified time horizon. Remember, high Tempest Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Tempest Therapeutics' market risk premium analysis include:
Beta 2.53 | Alpha (0.28) | Risk 6.32 | Sharpe Ratio 0.0102 | Expected Return 0.0643 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Tempest |
Tempest Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Tempest Therapeutics market risk premium is the additional return an investor will receive from holding Tempest Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tempest Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Tempest Therapeutics' performance over market.| α | -0.28 | β | 2.53 |
Tempest Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Tempest Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Tempest Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Tempest Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Tempest Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tempest Therapeutics shares will generate the highest return on investment. By understating and applying Tempest Therapeutics stock market price indicators, traders can identify Tempest Therapeutics position entry and exit signals to maximize returns.
Tempest Therapeutics Return and Market Media
The median price of Tempest Therapeutics for the period between Wed, Aug 14, 2024 and Tue, Nov 12, 2024 is 1.28 with a coefficient of variation of 13.63. The daily time series for the period is distributed with a sample standard deviation of 0.17, arithmetic mean of 1.24, and mean deviation of 0.15. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635 | 08/23/2024 |
2 | Acquisition by Dubensky Thomas W. of 102700 shares of Tempest Therapeutics subject to Rule 16b-3 | 08/28/2024 |
3 | Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 09/05/2024 |
4 | Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 09/20/2024 |
5 | Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial | 10/10/2024 |
About Tempest Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Tempest or other stocks. Alpha measures the amount that position in Tempest Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 1.28 | 0.45 | 0.43 | Days Of Inventory On Hand | 454.38 | 408.94 | 429.39 |
Tempest Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Tempest Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tempest Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Tempest Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Tempest Therapeutics. Please utilize our Beneish M Score to check the likelihood of Tempest Therapeutics' management manipulating its earnings.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Tempest Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.